Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guo-Sheng Hu

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Proteome Research|December 12, 2022
CPPA: A Web Tool for Exploring Proteomic and Phosphoproteomic Data in CancerGuo-Sheng Hu, Zao-Zao Zheng, Yao-Hui He, et al.
Cell Discovery|May 19, 2026
Spatial single-cell landscape of tumor-associated macrophages and their crosstalk with the tumor microenvironmentRui-Chao Nie, Guo-Sheng Hu, Shi-Qiang Cao, et al.
Molecular & Cellular Proteomics : MCP|January 30, 2025
Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular BiomarkersGuo-Sheng Hu, Zao-Zao Zheng, Yao-Hui He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2023
A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal CancerNan Ding, A-Bin You, Hu Yang, et al.
Molecular Cancer|March 8, 2022
Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axisSong-Tao Xue, Bin Zheng, Shi-Qiang Cao, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2022
A specific JMJD6 inhibitor potently suppresses multiple types of cancers both in vitro and in vivoRong-Quan Xiao, Ting Ran, Qi-Xuan Huang, et al.
Science Bulletin|October 19, 2025
Nuclear receptor ESRRA promotes ERα-positive breast cancer through dual action on super enhancers and promoters to regulate gene transcriptional programsZao-Zao Zheng, Lu Chen, Guo-Sheng Hu, et al.
Journal of Medicinal Chemistry|April 3, 2024
Peptide Inhibitor Targeting the Extraterminal Domain in BRD4 Potently Suppresses Breast Cancer Both <i>In Vitro</i> and <i>In Vivo</i>Qi-Xuan Huang, Da-Meng Fan, Zao-Zao Zheng, et al.
Plos Biology|April 10, 2026
Casein kinase 2-mediated phosphorylation of the splicing factor SF3B3 plays a key role in esophageal squamous cell carcinoma progressionDu-Chuang Wang, Jia-Yuan Li, Xiao-Bing Wang, et al.
Marine Life Science & Technology|May 26, 2026
Phosphoproteomics reveals essential regulatory roles of phosphorylation in marine oligotrophic bacteriaYu Zhang, Yao-Hui He, Zhang-Xian Xie, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Proteome Research|December 12, 2022
CPPA: A Web Tool for Exploring Proteomic and Phosphoproteomic Data in CancerGuo-Sheng Hu, Zao-Zao Zheng, Yao-Hui He, et al.
Cell Discovery|May 19, 2026
Spatial single-cell landscape of tumor-associated macrophages and their crosstalk with the tumor microenvironmentRui-Chao Nie, Guo-Sheng Hu, Shi-Qiang Cao, et al.
Molecular & Cellular Proteomics : MCP|January 30, 2025
Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular BiomarkersGuo-Sheng Hu, Zao-Zao Zheng, Yao-Hui He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2023
A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal CancerNan Ding, A-Bin You, Hu Yang, et al.
Molecular Cancer|March 8, 2022
Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axisSong-Tao Xue, Bin Zheng, Shi-Qiang Cao, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2022
A specific JMJD6 inhibitor potently suppresses multiple types of cancers both in vitro and in vivoRong-Quan Xiao, Ting Ran, Qi-Xuan Huang, et al.
Science Bulletin|October 19, 2025
Nuclear receptor ESRRA promotes ERα-positive breast cancer through dual action on super enhancers and promoters to regulate gene transcriptional programsZao-Zao Zheng, Lu Chen, Guo-Sheng Hu, et al.
Journal of Medicinal Chemistry|April 3, 2024
Peptide Inhibitor Targeting the Extraterminal Domain in BRD4 Potently Suppresses Breast Cancer Both <i>In Vitro</i> and <i>In Vivo</i>Qi-Xuan Huang, Da-Meng Fan, Zao-Zao Zheng, et al.
Plos Biology|April 10, 2026
Casein kinase 2-mediated phosphorylation of the splicing factor SF3B3 plays a key role in esophageal squamous cell carcinoma progressionDu-Chuang Wang, Jia-Yuan Li, Xiao-Bing Wang, et al.
Marine Life Science & Technology|May 26, 2026
Phosphoproteomics reveals essential regulatory roles of phosphorylation in marine oligotrophic bacteriaYu Zhang, Yao-Hui He, Zhang-Xian Xie, et al.
Pageof 3